The marijuana sector has experienced highs and lows over the past few years, with some cannabis stocks performing better than others.
Both new and sophisticated investors are interested in the cannabis market — legal marijuana has opened the doors for many new players in the industry looking to expand their investment options.
So, you’ve taken the plunge by investing in marijuana stocks. Now what?
After adding marijuana stocks to your portfolio, it’s important for to make sure these cannabis companies are delivering shareholder value.
The 2016 presidential election cycle brought a flurry of support for cannabis policies across the US. This year, five states will ask voters to decide on a variety of cannabis programs.
While cannabis regulation in the US can get bogged down by the development of federal bills — such as the recent Marijuana Opportunity, Reinvestment and Expungement Act (MORE Act) — the story is different at the state level, and several cannabis programs have launched thanks to voter support.
Cannabis legalization in Canada helped kickstart a financial revolution in the stock market with the launch of a diverse portfolio of marijuana stocks.
With the boom of public cannabis businesses in full swing, are you thinking about investing in cannabis companies? If so, consider starting your journey here.
The health of Elixinol Global (ASX:EXL) doesn’t tie directly to the medical cannabis market in Australia, but it does offer a clearer picture on the progress of this sector.
The company offers labelled products, along with bulk and wholesale hemp-derived cannabidiol (CBD), around the world. Its offerings have a variety of health- and wellness-related uses.
Investors are always looking for areas of growth in the overall public sector, and investing in the cannabis industry has proven to be a beneficial road to returns.
A budding legalization movement across the globe and an emerging US market set to create US$80 billion by 2030 have led many investors to be eager to invest in the space.